Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine hydrochloride and sodium valproate in plasma cell neoplasms
2011-001143-70Phase 2Active
- Sponsor
- Breno Moreno de Gusmao
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydralazine and valproic acid in plasma cell neoplasm, sponsored by Breno Moreno de Gusmao. Started Sep 2011; status: active.
02
Drugs
hydralazinevalproic acid
03
Conditions
plasma cell neoplasm
Beyond the preview
Go deeper on 2011-001143-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001143-70.